IL6 and Sepsis: Several studies have demonstrated that aptamer-based biosensors match or exceed antibody-based systems in sensitivity, often reaching femtomolar or even attomolar detection limits for sepsis-related biomarkers, such as IL-6, CRP, and tumor necrosis factor-alpha (TNF-α) [17,79].